Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab and social participation in ankylosing spondylitis
NL-OMON38200Recruiting
- Sponsor
- Maastricht University
- Start
- Mar 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of adalimumab in ankylosing spondylitis (AS), sponsored by Maastricht University. Primary endpoint: Change in importance-satisfaction gap of social participation areas. Started Mar 2012; status: recruiting.
02
Drugs
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NL-OMON38200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38200.